Loading...

BioInvent International AB (publ)

BOVNF•PNK
Healthcare
Biotechnology
$3.29
$0.00(0.00%)
U.S. Market opens in 3h 21m

BioInvent International AB (publ) (BOVNF) Stock Overview

Explore BioInvent International AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap216.4M
P/E Ratio-6.08
EPS (TTM)$-0.47
ROE-0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$3.10
3 Months$3.45
1 Year Target$4.51

BOVNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioInvent International AB (publ) (BOVNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.08 and a market capitalization of 216.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.04%
1-Month Change
-0.04%
3-Month Change
-0.04%
6-Month Change
-0.04%
Year-to-Date (YTD) Change
-0.04%
1-Year Change
-30.03%
3-Year Change
-30.03%
5-Year Change
-41.27%
All-Time (Max) Change
-50.17%

Contact Information

https://www.bioinvent.com
46 4 62 86 85 50
The Gamma Building, Lund, NaN, 223 70

Company Facts

114 Employees
IPO DateSep 3, 2013
CountrySE
Actively Trading

Frequently Asked Questions